TY - JOUR
T1 - Thioglycine and l-thiovaline
T2 - Biologically active H 2S-donors
AU - Zhou, Zongmin
AU - Von Wantoch Rekowski, Margarete
AU - Coletta, Ciro
AU - Szabo, Csaba
AU - Bucci, Mariarosaria
AU - Cirino, Giuseppe
AU - Topouzis, Stavros
AU - Papapetropoulos, Andreas
AU - Giannis, Athanassios
N1 - Funding Information:
This work has been co-financed by the European Union (European Social Fund –ESF) and Greek national funds through the operational Program ‘Education and Lifelong Learning’ of the National Strategic Reference Framework (NSRF) — Research Funding Program: Thalis, Investing in knowledge society through the European Social Fund to AP, by a grant from the Shriners’ Burns Hospitals (#8661) to CS and by the COST Action BM1005 (ENOG: European network on gasotransmitters). We thank also the University of Leipzig for financial support.
PY - 2012/4/15
Y1 - 2012/4/15
N2 - Thioglycine and l-thiovaline are stable under acidic and basic conditions but in the presence of bicarbonate they liberate the gasotransmitter H 2S. In cells both thioamino acids were proven to enhance cGMP formation and promote vasorelaxation in mouse aortic rings. Given that H 2S is known to lower arterial hypertension, reduce oxidative stress and exhibit cardioprotective effects in preclinical models, H 2S donors hold promise as novel treatments for cardiovascular diseases.
AB - Thioglycine and l-thiovaline are stable under acidic and basic conditions but in the presence of bicarbonate they liberate the gasotransmitter H 2S. In cells both thioamino acids were proven to enhance cGMP formation and promote vasorelaxation in mouse aortic rings. Given that H 2S is known to lower arterial hypertension, reduce oxidative stress and exhibit cardioprotective effects in preclinical models, H 2S donors hold promise as novel treatments for cardiovascular diseases.
KW - Gasotransmitters
KW - Hydrogen sulfidel
KW - Thioglycin
KW - Thiovalin
UR - http://www.scopus.com/inward/record.url?scp=84862807204&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84862807204&partnerID=8YFLogxK
U2 - 10.1016/j.bmc.2012.02.028
DO - 10.1016/j.bmc.2012.02.028
M3 - Article
C2 - 22436388
AN - SCOPUS:84862807204
SN - 0968-0896
VL - 20
SP - 2675
EP - 2678
JO - Bioorganic and Medicinal Chemistry
JF - Bioorganic and Medicinal Chemistry
IS - 8
ER -